Materialise NV - ADR

The total asset value of Materialise NV - ADR stood at $ 489 Mln as on 31-Mar-25

The share price of Materialise NV - ADR is $5.21 (NASDAQ) as of 29-Apr-2025 16:00 EDT. Materialise NV - ADR has given a return of -32.39% in the last 3 years.

Materialise NV - ADR has a market capitalisation of $ 312 Mln as on 28-Apr-2025. As per Value Research classification, it is a company.

The P/B ratio of Materialise NV - ADR is 1.08 times as on 28-Apr-2025, a 84% discount to its peers’ median range of 6.88 times.

The P/E ratio of Materialise NV - ADR is 28.67 times as on 28-Apr-2025, a 77% discount to its peers’ median range of 123.47 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Materialise NV - ADR and enter the required number of quantities and click on buy to purchase the shares of Materialise NV - ADR.

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium. Address: Technologielaan 15, Leuven, Belgium, 3001

The CEO & director of Ms. Brigitte de Vet-Veithen. is Materialise NV - ADR, and CFO & Sr. VP is Ms. Brigitte de Vet-Veithen.

There is no promoter pledging in Materialise NV - ADR.

Some of the close peers are:

No, TTM profit after tax of Materialise NV - ADR was $0 Mln.